Antisoma has edged lower after further board changes that have led to Michael Bretherton, the finance director of 17.5% shareholder ORA, becoming a director.

Antisoma chairman Barry Price and non-executive director Birgit Stattin-Norinder have both resigned. Grahame Cook takes over as chairman.

At the beginning of the week, the chief executive and finance director resigned. Finance director Eric Dodd remains a consultant.

Drug developer Skyepharma is higher following reports that it has narrowed down its search for a US partner for asthma treatment Flutiform.

The list has been reduced to four or five companies following discussions with more than 20 firms.

Abbott Laboratories was the original US partner but it pulled out last summer.

FTSE TechMARK - Risers
Micro Focus International Plc (MCRO) 306.30p +7.62%
Skyepharma (SKP) 42.00p +5.00%
Emblaze Ltd. (BLZ) 41.50p +3.11%
Domino Printing Sciences (DNO) 654.50p +1.95%
Corin Group (CRG) 43.00p +1.18%
Autonomy Corporation (AU.) 1,664.00p +0.73%
XP Power Ltd. (DI) (XPP) 1,815.00p +0.67%
Vodafone Group (VOD) 175.50p +0.60%
Promethean World (PRW) 58.00p +0.43%
NCC Group (NCC) 555.00p +0.36%

FTSE TechMARK - Fallers
Torotrak (TRK) 28.75p -5.74%
Antisoma (ASM) 2.70p -5.26%
RM (RM.) 147.25p -4.23%
KCOM Group (KCOM) 63.00p -3.82%
Anite (AIE) 66.00p -3.65%
Innovation Group (TIG) 15.75p -3.08%
Gresham Computing (GHT) 31.00p -2.36%
Electronic Data Processing (EDP) 52.00p -1.89%
Kewill (KWL) 92.25p -1.86%

Related share prices
Skyepharma (SKP) share price
Antisoma (ASM) share price
ORA Capital Partners Ltd (ORA) share price